WuXi Biologics is a young biologics contract development and manufacturing organization, or CDMO. It is rapidly building up capacity to become comparable in size to the top three players. It is the ...
The medical device industry is experiencing significant changes, and contract development and manufacturing organizations (CDMOs) are playing a crucial role. This Q&A explores Albert Weng's role as ...
A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the ...
As pipelines across modalities diversify, regulatory scrutiny intensifies, and the margin for error in development execution continues to shrink, partnering with a CDMO has never been more critical.
The use of biologics is rapidly increasing as new drugs are approved for label expansions. Monoclonal antibodies, multispecific antibodies, and antibody-drug conjugates (ADCs) are being implemented in ...
WuXi Biologics is a young biologics contract development and manufacturing organization, or CDMO. It is rapidly building up capacity to become comparable in size to the top three players. It is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results